[ad_1]
“There now appears to be some evidence that the new option … may be related to higher mortality,” the prime minister told a news conference in Downing Street.
Patrick Vallance, the government’s top scientific adviser, said the new strain of coronavirus could cause up to about 30 percent. higher patient mortality, but noted that detailed data on this topic are not yet available.
The expert said that around 10 out of every 1,000 men in their 60s died from being infected with the most common strains of coronavirus that had spread so far.
However, the new strain results in an increase in mortality in this age group to 13-14 deaths per thousand patients.
“You will see that in other age groups too [pasireiškia] an increase in relative risk of a similar nature, ”Vallance said.
Britain is currently affected by the third and worst wave of the COVID-19 coronavirus infection epidemic to date. The country has registered daily mortality records in recent weeks, with a total number of victims close to 100,000.
1,401 more deaths were reported Friday no later than 28 days after they were confirmed to have a coronavirus infection. The total number of victims of the pandemic in Great Britain rose to 95,981.
Currently, more than 38.5 thousand people receive treatment in hospitals in the United Kingdom. 78% of COVID-19 patients. more than during the peak of the first wave last year.
Medical Director Chris Whitty said that an average of one in 55 people in England is infected with the coronavirus and an average of one in 35 people in London.
While the morbidity curve appears to flatten, hospitals are in danger of being overcrowded and the government is in a rush to vaccinate as many vulnerable groups as possible.
Johnson said that about 5.3 million people had already received the first dose of the vaccine in the country. people, so the government is approaching the goal of vaccinating 15 million people by mid-February. the most vulnerable.
According to Vallance, “there is growing evidence” that both the vaccine, developed by AstraZeneca and the University of Oxford, as well as Pfizer and BioNTech, are effective in protecting against a new strain of coronavirus.
It is strictly prohibited to use the information published by DELFI on other websites, in the media or elsewhere, or to distribute our material in any way without consent, and if consent has been obtained, it is necessary to indicate DELFI as the source.
[ad_2]
